Topics
Sections
Companies
Browse by topic
Unicorns
Soonicorns
Listed tech
Investors
Latest news, articles, and AI insights covering Recursion Pharmaceuticals.
Enveda raises $311 million in Series E funding at a $2 billion valuation, using AI to discover drugs from natural sources and advance them into clinical trials.
